Dalid, Jerlyn T.

HRN: 06-30-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CEFAZOLIN 1GM (VIAL)
06/28/2026
06/28/2026
IV
2gms
PTOR
STAT CS
Remove - Pending Acceptance
06/28/2026
CEFAZOLIN 1GM (VIAL)
06/28/2026
06/29/2026
IV
1gm
Q8hrs X 3 Doses
S/P Primary LSTCS
Remove - Pending Acceptance
06/29/2026
CEFUROXIME 500MG (TAB)
06/29/2026
07/06/2026
ORAL
500mg
BID
S/P CS
Remove - Pending Acceptance
06/30/2026
MUPIROCIN 2%, 15G (TUBE)
06/30/2026
07/07/2026
TOPICAL
2%
BID
S/P PLSTCS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: